A giant “Mega Lung” at START Cancer Center lets visitors walk through lungs while doctors raise awareness about lung disease, ...
9h
Boehringer awarded FDA Commissioner's National Priority Voucher for HERNEXEOS(R) in HER2 lung cancer
Boehringer recently reported positive results from the Beamion LUNG-1 trial evaluating zongertinib in treatment-naïve patients with advanced NSCLC at ESMO 2025. The company is pursuing regulatory ...
Lung cancer is one of the deadliest cancers, with 64 percent survival rates for early detection but only 8 percent for ...
Radiology and early detection for lung cancer screening are a partnership for success. Lung cancer remains the leading cause of cancer deaths in America, claiming more lives each year than breast, ...
The U.S. Food & Drug Administration (FDA) has awarded a Commissioner's National Priority Voucher (CNPV) for HERNEXEOS® ...
In the commonwealth of Kentucky, the burden of lung cancer remains alarmingly high. According to the American Lung ...
Persistent cough, fatigue, and breathlessness symptoms like these can point to either pneumonia or lung cancer. Experts say ...
A low-dose CT screening people people at high risk can reduce the death rate from lung cancer by up to 20 percent, but only a ...
A pulmonologist at the Cleveland Clinic shares the lung cancer warning signs he looks for in his own body. The deadly disease ...
Lung cancer can enter a person's life like a tornado, creating chaos out of nowhere and leaving them feeling powerless.
Please provide your email address to receive an email when new articles are posted on . Surgery and stereotactic ablative radiotherapy conferred comparable 10-year survival among patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback